BCVA Results Better Maintained With Monthly Ranibizumab Treatments
Monthly injections with ranibizumab maintained best corrected visual acuity results better than did quarterly injections in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration, according to a study.